Compare key investment metrics of SK바이오팜 and 950160 in real time. Both stocks belong to the 세포유전자치료(CGT) 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 950160 is larger — ₩7.5T vs SK바이오팜's ₩6.6T. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- SK바이오팜's current price of 84,000원 sits at about 5% of its 52-week range (80,300원–147,800원).
- 950160's current price of 88,300원 sits at about 46% of its 52-week range (35,800원–149,000원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | SK바이오팜 | 950160 |
|---|---|---|
| Price | 84,000원 | 88,300원 |
| PER | 18.86배 | - |
| PBR | 7.06배 | 59.5배 |
| Market Cap | ₩6.6T | ₩7.5T |
| 52-Week High | 147,800원 | 149,000원 |
| 52-Week Low | 80,300원 | 35,800원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, SK바이오팜 or 950160?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest SK바이오팜 and 950160 PER values.
What is the dividend yield difference between SK바이오팜 and 950160?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of SK바이오팜 and 950160 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare SK바이오팜 and 950160?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.